VC firms
Wyss Zurich is a joint research and development center of the University of Zurich and the ETH Zurich, made possible by a generous donation from the Swiss entrepreneur and philanthropist Dr. hc. mult. Hansjörg Wyss. The mission of Wyss Zurich is to drive the clinical translation and technology transfer of outstanding scientific discoveries into new therapies for patients and breakthrough innovations in the emerging fields of Regenerative Medicine and Robotics, and to promote hybrid technologies in these fields. Wyss Zurich brings together some of the world’s leading experts to form multidisciplinary teams, pooling their knowledge and expertise.
Overview
Location
Switzerland, Zurich
Employees
51-200
Founded date
2014
Investment Type
Accelerator
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 26, 2025 | CHF 150,000 propel hands-free wheelchair steering | Manual wheelchairs still rely on differential steering, requiring users to brake with one hand to control direction. This inefficient method wastes up to one-third of users’ energy, increases the risk of shoulder injuries, and makes daily ... |
| Oct 8, 2024 | CHF 10 million to advance Somagenetix' first gene therapy candidate into a clinical trial | Founded in 2019, as a spin-off of the University of Zurich (UZH), Somagenetix AG is at the forefront of gene therapy innovation, focused on curing phagocyte disorders with a one-time treatment. The company has built a best-in-class gene th... |
| Apr 19, 2024 | Wyss Zurich expands portfolio | Wyss Zurich is a joint accelerator of the University of Zurich and ETH Zurich, funded by a generous donation from the Swiss entrepreneur and philanthropist Dr Hansjörg Wyss. By providing projects with capital and access to infrastructure a... |
| Apr 4, 2024 | The top 15 startups in de Vigier Award revealed | More than 200 candidates applied for the 2024 W.A de Vigier Award, one of the most important competitions in the Swiss startup ecosystem, and only 50 made it to the shortlist. During the selection Day on February 28, the jury nominated the... |
| Jun 12, 2023 | California-based company acquires Seervision | |
| Mar 27, 2023 | The Biomedical Entrepreneurship ecosystem: Turning cutting-edge research into viable ventures | The Biomedical Entrepreneurship ecosystem: Turning cutting-edge research into viable ventures 27.03.2023 08:00, Morgane Ghilardi linkedIn facebook twitter instagram youtube --> Strengthening the pipeline between academic research and ent... |
| Feb 13, 2023 | Swiss-based Nanoflex Robotics bags €11.2M for its robotic endovascular navigation platform | Zurich-based Nanoflex Robotics, a company that provides advanced medical robotic interventions for treating ischemic stroke, announced that it has raised over $12M (approximately €11.23M) in a Series A round of funding. The medtech startup ... |
| Feb 10, 2023 | ETH medtech spinoff secures USD 12 million | |
| Oct 27, 2022 | Muvon Therapeutics announces First Patient Enrolled in Phase II Clinical Study in Female Patients with Stress Urinary Incontinence using Novel Regenerative Cell Therapy | Muvon Therapeutics announces First Patient Enrolled in Phase II Clinical Study in Female Patients with Stress Urinary Incontinence using Novel Regenerative Cell Therapy Thu, Oct 27, 2022 09:09 CET Report this content Zurich, Switzerland, Oc... |
Reviews 0
FAQ about Wyss Zurich
When was Wyss Zurich founded?
Wyss Zurich was founded in 2014.
What has the press written about Wyss Zurich?
Parsers VC has collected 10 articles mentioning Wyss Zurich, among them “CHF 150,000 propel hands-free wheelchair steering” (May 26, 2025) and “CHF 10 million to advance Somagenetix' first gene therapy candidate into a clinical trial” (Oct 8, 2024).
Is Wyss Zurich still active?
Yes, Wyss Zurich is active; its latest activity on Parsers VC dates from Nov 14, 2025.